VIP Research Peptide – Specifications, Testing & Procurement Guide
Selecting a VIP research peptide requires researchers to evaluate both scientific relevance and commercial product specifications.
VIP—vasoactive intestinal peptide—is a defined 28-amino-acid neuropeptide with research relevance across receptor signaling, gastrointestinal biology, immune pathways, inflammatory signaling, and neuroimmune systems.
However, scientific relevance alone doesn’t verify a commercial research product.
Procurement requires a separate product-specific evaluation.
What Is VIP Research Peptide?
VIP stands for vasoactive intestinal peptide.
It is a 28-amino-acid peptide investigated in numerous experimental systems.
Major research areas include:
- VPAC1 receptor signaling
- VPAC2 receptor signaling
- GPCR pathways
- cAMP-associated signaling
- Gastrointestinal physiology
- Intestinal epithelial biology
- Immune-cell responses
- Cytokine and chemokine pathways
- Inflammatory signaling
- Neuroimmune biology
VIP Receptor Biology
VIP primarily interacts with:
VPAC1
and
VPAC2
These receptors belong to the class B GPCR family.
Their distribution and expression can differ among tissues and cell types.
This means VIP responses can depend significantly on the experimental model.
VIP and PAC1 Are Not Equivalent
PAC1 belongs to the related receptor family and is principally PACAP-preferring.
Researchers shouldn’t present PAC1 as an equivalent primary VIP receptor.
For VIP-focused experimental design, VPAC1 and VPAC2 should remain the central receptor terminology.
Browse VIP Research Products
https://peptideslabus.com/products?q=VIP
The catalog provides a central location for reviewing currently listed VIP research products.
Individual VIP Research Product
https://peptideslabus.com/products/crown-vip
Researchers should review current specifications directly from the product page.
Additional VIP Product
https://peptideslabus.com/products/peptides-lab-vip
This provides another standalone listing for product-specific evaluation.
Gastrointestinal Research Bundle
https://peptideslabus.com/products/crown-gastrointestinal-research-bundle
Researchers conducting broader gastrointestinal research can determine whether a multi-compound configuration matches their experimental protocol.
Specification 1: Molecular Identity
The first question is:
What compound is supplied?
The intended research material should be vasoactive intestinal peptide.
“VIP” alone can be ambiguous outside peptide research.
Exact molecular identification matters.
Specification 2: Peptide Length
VIP is a defined 28-amino-acid peptide.
Peptide length is one component of molecular identification.
Researchers should review complete molecular information where available.
Specification 3: Sequence
Sequence information provides another reference for verifying the intended peptide.
This becomes especially useful when distinguishing VIP from related peptides within the secretin/glucagon peptide family.
Specification 4: Quantity
Researchers should determine exactly how much research material is supplied.
Required quantity depends on:
- Experimental conditions
- Controls
- Replicates
- Time points
- Assays
- Repeated experiments
Specification 5: Purity
A reported purity percentage should be interpreted within analytical context.
Researchers should ask:
- Which method generated it?
- Which sample was analyzed?
- Which batch was tested?
- Is supporting documentation available?
Specification 6: HPLC
High-performance liquid chromatography is commonly used in peptide analysis.
HPLC can provide chromatographic purity information.
Researchers should review the analytical result rather than relying exclusively on promotional wording.
Specification 7: Molecular Identity Testing
Chromatographic purity doesn’t automatically establish complete molecular identity.
Researchers should separately evaluate available identity-related analytical information.
Specification 8: Certificate of Analysis
A COA may contain:
- Compound identification
- Product information
- Batch or lot
- Analytical method
- Purity
- Identity-related information
- Additional specifications
Researchers should determine what the certificate actually establishes.
Specification 9: Batch Information
Analytical results may be batch-specific.
Researchers should determine whether documentation corresponds to the material being considered for procurement.
Specification 10: Product Configuration
Researchers should distinguish between:
standalone VIP research peptide
and
multi-compound research configurations.
The correct choice depends on the experimental design.
Specification 11: Price
Price should be compared with:
- Quantity
- Product configuration
- Purity
- Testing
- Documentation
Price alone doesn’t establish product quality.
Specification 12: Availability
Inventory can change.
Researchers should verify current product status through:
https://peptideslabus.com/products?q=VIP
immediately before procurement.
VIP and Immune Research
VIP has been investigated experimentally in systems involving:
- T cells
- Macrophages
- Dendritic cells
- Cytokines
- Chemokines
- Innate immune pathways
- Adaptive immune pathways
The biological response can vary by receptor expression and experimental context.
VIP and Inflammatory Signaling
Research has examined VIP within inflammatory signaling networks.
However, describing VIP simply as “anti-inflammatory” can oversimplify complex, context-dependent biology.
Research content should identify the experimental pathway rather than imply universal effects.
VIP and Gastrointestinal Research
VIP has significant research relevance in gastrointestinal biology.
Experimental research includes areas involving:
- Intestinal signaling
- Secretory processes
- Motility-associated mechanisms
- Epithelial function
- Mucosal immune biology
- Barrier-related mechanisms
This provides a scientifically coherent reason to consider gastrointestinal research configurations when appropriate.
VIP and Neuroimmune Research
VIP is a neuropeptide with research relevance at the interface of neuronal and immune signaling.
Experimental studies may investigate:
- Receptor expression
- Immune-cell responses
- Cytokine signaling
- Neuroimmune communication
- Downstream intracellular pathways
Scientific Evidence vs Product Verification
Published VIP research can provide evidence about biological mechanisms.
It doesn’t establish:
- Purity of a commercial product
- Identity of a particular vial
- Product quantity
- Batch consistency
- Current price
- Current availability
Those require product-specific information.
VIP Research Peptide Procurement Checklist
Before purchasing:
- Confirm vasoactive intestinal peptide is the intended compound.
- Verify the expected 28-amino-acid peptide identity.
- Review sequence information.
- Determine the required quantity.
- Decide whether standalone or multi-compound format fits the study.
- Review purity.
- Examine HPLC information.
- Review identity-related testing.
- Examine the COA.
- Check batch information.
- Compare current price.
- Verify current availability.
- Preserve VPAC1/VPAC2 receptor accuracy.
- Keep published biological research separate from commercial product verification.
Browse VIP Research Products
https://peptideslabus.com/products?q=VIP
A strong VIP research peptide procurement decision combines scientific relevance, molecular identity, product specifications, analytical testing, documentation, quantity, price, and current availability.
For laboratory research purposes only.